A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/26/2006	US7153864 Polyglutamic acid-camptothecin conjugates and methods of preparation
12/26/2006	US7153863 Therapeutic compounds based on pyrazolopyridline derivatives
12/26/2006	US7153862 αv integrin receptor antagonists
12/26/2006	US7153861 5,6 -Trimethylenepyrimidin-4-one compounds
12/26/2006	US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
12/26/2006	US7153858 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
12/26/2006	US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds
12/26/2006	US7153854 Pyrrolopyridazine derivatives
12/26/2006	US7153853 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
12/26/2006	US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006	US7153851 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
12/26/2006	US7153850 Lactam compounds and pharmaceutical use thereof
12/26/2006	US7153849 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder
12/26/2006	US7153848 13-C5-7-cycloalkylindolo[2.1-a][2]benzazepine derivatives; e.g., 3-[3-[3-[1-[[(13-cyclohexyl-7H-indolo[2,1-a][2]benzazepin-10-yl)carbonyl]amino]cyclopentyl]-1,2,4-oxadiazol-5-yl]phenyl]-(2E)-2-propenoic acid
12/26/2006	US7153847 Dipeptide-substituted benzo- and dibenzocaprolactams, which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease
12/26/2006	US7153846 2-(3,4,5-trihydroxy-2-methoxy-8-methyl-6-decenoylamino)-E-caprolactams that may be esterified; treatment of cancer, especially cancers of the breast, colon, lung, and prostate and glioblastomas and leukemia
12/26/2006	US7153845 Sustained release of testosterone
12/26/2006	US7153844 Estrogen-linked platinum (II) complexes as anticancer agents
12/26/2006	US7153843 Anticancer agents; antitumor agents
12/26/2006	US7153842 Phosphate esters of florfenicol that may be hydrolyzed to form free florfenicol, e.g., 1R,2S-1-(4-Methanesulfonylphenyl)-2-(2,2-dichloroacetylamino)-3-fluoropropyl]-di-tert-butyl phosphate
12/26/2006	US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis
12/26/2006	US7153840 Aqueous fludarabine phosphate composition
12/26/2006	US7153838 Pharmacologically acceptable solvent vehicles
12/26/2006	US7153837 Agent for protection of retinal neurons
12/26/2006	US7153826 Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
12/26/2006	US7153824 Inhibitors of phosphodiesterases in infertility
12/26/2006	US7153814 Amidoacetonitrile derivatives
12/26/2006	US7153809 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
12/26/2006	US7153677 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153649 Applying stresses to blood sampling
12/26/2006	US7153527 Iodine-propylene glycol teat dip
12/26/2006	US7153524 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal
12/26/2006	US7153522 bases comprising isoprene-styrene block copolymer and/or polyisobutylene, softeners and tackifier resins, hexylene glycol and 1-menthol as skin absorption intensifiers, and hormones as the drug components
12/26/2006	US7153519 Implantable substrate coated with a macromer having free radical polymerizable substituents
12/26/2006	US7153514 Use of botulinum toxin therapy for prostatic hyperplasia and related disorders
12/26/2006	US7153506 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family
12/26/2006	US7153502 Food or drink product with a disinfection property of Helicobacter pylori
12/26/2006	US7153499 Promoting differentiation and maturation of immature dendritic cells in a regional lymph node (especially by administering a natural cytokine mixture parilymphatically) so that the cells deliver T-cell antigen to effect immunization
12/26/2006	US7153498 Water-in-oil emulsion and its use as a cosmetic
12/26/2006	US7153497 Exhibiting constant release rate and delayed release profiles
12/26/2006	US7153494 Dibenzoylmethane sunscreen compositions photostabilized with amphiphilic block copolymers
12/26/2006	US7153492 prophylactic or wound-healing treatment of lactating animals prone to develop or suffering from mastitis; chitosan, its derivatives and salts thereof and a second component capable of releasing CO2 in an acidic environment
12/21/2006	WO2006135915A2 Methods and compositions for treating degenerative bone disorders
12/21/2006	WO2006135894A1 Compositions and methods for treating inflammatory conditions
12/21/2006	WO2006135873A2 Parp modulators and treatment of cancer
12/21/2006	WO2006135862A2 Immunomodulation by altering sphingosine 1-phosphate lyase (spl) activity
12/21/2006	WO2006135860A1 Sulfonamide compounds and uses thereof
12/21/2006	WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	WO2006135804A1 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same
12/21/2006	WO2006135796A2 Crystalline forms of a pyrrolotriazine compound
12/21/2006	WO2006135795A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
12/21/2006	WO2006135790A1 Methods of identifying and treating individuals exhibiting mutant kit protein
12/21/2006	WO2006135785A2 Compositions and methods for treating immune disorders
12/21/2006	WO2006135721A1 Alkylquinoline and alkylquinazoline kinase modulators
12/21/2006	WO2006135719A1 Aminopyrimidines as kinase modulators
12/21/2006	WO2006135718A1 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
12/21/2006	WO2006135715A1 Benztropinamine analogs as dopamine uptake inhibitors
12/21/2006	WO2006135694A2 Uii-modulating compounds and their use
12/21/2006	WO2006135693A2 Direct compression formulation of dpp-iv inhibitors and glitazones, and process
12/21/2006	WO2006135687A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
12/21/2006	WO2006135667A1 Imidiazo -and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
12/21/2006	WO2006135644A1 Aminopyrimidines as kinase modulators
12/21/2006	WO2006135639A1 Thiξnopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors
12/21/2006	WO2006135635A2 Topical compositions and methods for alleviating or inhibiting symptoms associated with carpal tunnel syndrome, acid reflux, psoriasis, cartilage nodules, fibromyalgia, and diabetes
12/21/2006	WO2006135630A1 Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
12/21/2006	WO2006135629A1 Synergistic modulation of flt3 kinase using alkylquinolines and alkylquinazolines
12/21/2006	WO2006135627A2 Inhibitors of akt activity
12/21/2006	WO2006135621A2 Method for renin-angiotensin-aldosterone system activation and control thereof
12/21/2006	WO2006135605A2 Formulation of a thienopyridine platelet aggregation inhibitor
12/21/2006	WO2006135604A2 Inhibitors of checkpoint kinases
12/21/2006	WO2006135545A2 A method for the prevention and/or treatment of neurodegenerative diseases characterized by administering an ep1 receptor antagonist
12/21/2006	WO2006135480A2 Oral pharmaceutical formulations comprising fenofibric acid and/or its salts
12/21/2006	WO2006135445A2 Antimicrobial chelates
12/21/2006	WO2006135406A2 Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
12/21/2006	WO2006135383A2 Indazoles
12/21/2006	WO2006135362A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
12/21/2006	WO2006135344A1 A photosensitising composition and uses thereof
12/21/2006	WO2006135323A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
12/21/2006	WO2006135316A1 New oxabispidine compounds for the treatment of cardiac arrhythmias
12/21/2006	WO2006135312A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
12/21/2006	WO2006135280A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
12/21/2006	WO2006135254A1 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
12/21/2006	WO2006135084A1 Prophylactic or therapeutic agent for steatohepatitis or fatty liver
12/21/2006	WO2006135083A1 Prophylactic or therapeutic agent for visceral fat syndrome
12/21/2006	WO2006135080A1 Thienopyrimidine derivative
12/21/2006	WO2006134989A1 Nitrogenated heterocyclic compound
12/21/2006	WO2006134970A1 Coenzyme q10-containing water-soluble composition and process for production thereof
12/21/2006	WO2006134963A1 Agent for fibrous disease comprising oxaluric acid derivtive
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134937A1 Skin preparation for external use
12/21/2006	WO2006134890A1 Composition for protection of body surface
12/21/2006	WO2006134877A1 Injection
12/21/2006	WO2006134864A1 Solubilization preparation
12/21/2006	WO2006134613A2 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors
12/21/2006	WO2006134611A1 Compositions of antiulcerative substituted benzimidazoles
12/21/2006	WO2006134610A1 Efavirenz pharmaceutical composition having enhanced dissolution profile

1 ... 3953 3954 3955 3956 3957 3958 3959 3960 3961 3962 3963 3964 3965 3966 3967 3968 3969 3970 3971 3972 3973 ... 7860